# DALY II USA/ MB-CART2019.1 for DLBCL

Source: https://onco.cc/trials/nct04792489/  
OnCo record `nct04792489` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Zamtocabtagene autoleucel, Cyclophosphamide, Fludarabine in diffuse large b-cell lymphoma and mantle cell lymphoma, run by Miltenyi Biomedicine GmbH, now recruiting.

## Summary

DALY II USA/ MB-CART2019.1 for DLBCL is a phase 2 interventional study registered as NCT04792489 by Miltenyi Biomedicine GmbH, with 315 participants planned, started 2021-05-25 and due to reach its primary completion in 2026-12-31. Interventions recorded: zamtocabtagene autoleucel (MB-CART2019.1), Cyclophosphamide, Fludarabine, Bendamustine. Conditions listed: Refractory Diffuse Large B Cell Lymphoma (DLBCL), Relapsed Diffuse Large B Cell Lymphoma, High Grade B-cell Lymphoma (HGBCL), Primary Mediastinal B-cell Lymphoma (PMBCL). No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT04792489
- Phase: 2
- Setting: A Multi-center Single Arm Phase II Study to Evaluate the Safety and Efficacy of Genetically Engineered Autologous Cells Expressing Anti-CD20 and Anti-CD19 Specific Chimeric Antigen Receptor in Subjects With Relapsed and/or Refractory Diffuse Large B Cell Lymphoma
- Sponsor: Miltenyi Biomedicine GmbH
- Enrolled: 315

## Sources

- ClinicalTrials.gov NCT04792489: https://clinicaltrials.gov/study/NCT04792489

## Connected records

- cancers: [Diffuse large B-cell lymphoma](https://onco.cc/cancers/dlbcl/), [Mantle cell lymphoma](https://onco.cc/cancers/mantle-cell-lymphoma/)
- drugs: [Bendamustine](https://onco.cc/drugs/bendamustine/), [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Fludarabine](https://onco.cc/drugs/fludarabine/), [Zamtocabtagene autoleucel](https://onco.cc/drugs/zamtocabtagene-autoleucel/)
- companies: [Miltenyi Biomedicine](https://onco.cc/companies/miltenyi-biomedicine/)

---
JSON: https://onco.cc/api/v1/entities/nct04792489.json